Efficacy and safety of trelagliptin in combination with insulin therapy in Japanese patients with type 2 diabetes: Results from a randomized, Phase IV study

We aimed to explore the efficacy and safety of once‐weekly trelagliptin 100 mg as an add‐on therapy to insulin in Japanese patients with type 2 diabetes mellitus with inadequate glycaemic control. Patients with haemoglobin A1c (HbA1c) 7.5% to 10.0% who were receiving 8 to 40 units of insulin per day...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaku, Kohei, Kuroda, Shingo, Ishida, Kazuyuki, Umeda, Yuusuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2018
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175153/
https://www.ncbi.nlm.nih.gov/pubmed/29862617
http://dx.doi.org/10.1111/dom.13397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175153/
https://www.ncbi.nlm.nih.gov/pubmed/29862617
http://dx.doi.org/10.1111/dom.13397

Ejemplares similares